NovaBay Pharmaceuticals to Participate in Virtual 33rd Annual Roth Conference

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay Pharmaceuticals (NYSE American: NBY), a pharmaceutical company focusing on commercializing Avenova® for the eye care market and CelleRx® Clinical Reset™ for the beauty market, announces that management will hold one-on-one investor meetings at the Virtual 33rd Annual Roth Conference being held March 15-17, 2021. Investors interested in arranging a meeting with NovaBay management should contact their Roth Capital Partners sales representative or LHA I